SOCRATESVirtual Reality Tool for Obesity Treatment: A Clinical Efficacy Study
This study aims to evaluate the effectiveness of a Virtual Reality tool in increasing your readiness to change towards achieving a healthy weight and exercising more, using measures such as Readiness Rulers and the Spanish version of the Stages and Processes of Change in Overweight and Obese People.
Experimental Group 1: Body swapping VR intervention + psychoeducational video + Treatment As usual
+ Experimental Group 2: VR intervention without body swapping + psychoeducational video + Treatment As usual
+ Control Group: Psychoeducational video + Treatment As usual
Body Weight+6
+ Nutrition Disorders
+ Nutritional and Metabolic Diseases
Treatment Study
Summary
Study start date: January 31, 2022
Actual date on which the first participant was enrolled.This study is part of the European Union's H2020 project, SOCRATES, and it aims to evaluate the effectiveness of a Virtual Reality (VR) tool in treating obesity. The focus is on comparing this new VR approach to traditional care methods. The study is specifically designed for individuals struggling with obesity. The importance of this research lies in its potential to introduce a new, innovative method for obesity treatment, which could improve care and address current challenges in weight management. During the study, participants will use a VR tool designed to help them manage their weight. The effectiveness of this tool will be measured using 'Readiness Rulers', which are scales ranging from 1 to 10. These scales assess the participant's 'Importance', 'Confidence', and 'Readiness' to change in terms of achieving a healthy weight and exercising more. Additionally, the Spanish version of the 'Stages of Change in Overweight and Obese People' and the 'Processes of Change in Overweight and Obese People' will be used. These tools help understand the participant's stage of change and their use of different processes to manage their weight. The study's primary focus is on the 'Readiness' scale, which is considered the critical response variable.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.96 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 65 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Vall d'Hebron University Hospital, Psychiatry Department; Vall d'Hebron Institute of Research
Barcelona, SpainOpen Vall d'Hebron University Hospital, Psychiatry Department; Vall d'Hebron Institute of Research in Google Maps